Trials / Terminated
TerminatedNCT05191628
Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- TBF Genie Tissulaire · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this open, multicenter trial is to assess the impact of the use of an amniotic membrane graft on the closure of macular hole-associated retinal detachment in patients with failed previous macular surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Visio-AMTRIX | Chemically-treated, viro-inactivated, freeze-dried and irradiated amniotic membrane placed by the investigator during macular hole surgery |
Timeline
- Start date
- 2020-06-10
- Primary completion
- 2022-10-10
- Completion
- 2022-10-10
- First posted
- 2022-01-13
- Last updated
- 2023-05-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05191628. Inclusion in this directory is not an endorsement.